Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

about

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

Item

http://www.wikidata.org/entity/Q54976917

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@en

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@nl

type

Item

label

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@en

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@nl

prefLabel

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@en

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@nl

P1476

Elucidation of the critical epitope of an anti-EGFR monoclonal antibody EMab-134.

@en

P2093

Mika K Kaneko

http://www.w3.org/2001/XMLSchema#string

Miyuki Yanaka

http://www.w3.org/2001/XMLSchema#string

Shinji Yamada

http://www.w3.org/2001/XMLSchema#string

Shunsuke Itai

http://www.w3.org/2001/XMLSchema#string

Takuro Nakamura

http://www.w3.org/2001/XMLSchema#string

Yao-Wen Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of the complex of human epidermal growth factor and receptor extracellular domains

The epidermal growth factor receptor as a target for cancer therapy.

The EGF receptor family as targets for cancer therapy.

Structural analysis of the EGFR/HER3 heterodimer reveals the molecular basis for activating HER3 mutations

Necitumumab for non-small cell lung cancer.

Extracellular region of epidermal growth factor receptor: a potential target for anti-EGFR drug discovery.

Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts.

Brigatinib combined with anti-EGFR antibody overcomes osimertinib resistance in EGFR-mutated non-small-cell lung cancer.

Development of EMab-51, a Sensitive and Specific Anti-Epidermal Growth Factor Receptor Monoclonal Antibody in Flow Cytometry, Western Blot, and Immunohistochemistry.

Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody.

P304

54-57

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBREP.2018.03.010

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yukinari Kato

P577

2018-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29872734

http://www.w3.org/2001/XMLSchema#string

P932

5986659

http://www.w3.org/2001/XMLSchema#string